 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
Bristol-Myers Squibb Applies to Sell New AIDS Drug in Europe
May 30, 2002 Bristol-Myers Squibb said Wednesday it has applied to the European equivalent of the US Food and Drug Administration for clearance to market and sell Atazanavir, a drug currently in development for the treatment of HIV/AIDS. The drug is a viral protease inhibitor that has shown potential for once-daily use, Bristol scientists said. Trials have included more than 1,500 patients whose conditions run the spectrum of HIV infection.
Excerpted from:
Back to other CDC news for May 30, 2002 Associated Press 05.29.02 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printer Friendly
Glossary
Share
